It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Reciprocal Copy Number Variants (CNVs) at the 16p11.2 locus confer high risk for autism spectrum disorder (ASD) and other neurodevelopmental disorders (NDDs). Morphometric MRI studies have revealed large and pervasive volumetric alterations in carriers of a 16p11.2 deletion. However, the specific neuroanatomical mechanisms underlying such alterations, as well as their developmental trajectory, are still poorly understood. Here we explored differences in microstructural brain connectivity between 24 children carrying a 16p11.2 deletion and 66 typically developing (TD) children between 2 and 8 years of age. We found a large pervasive increase of intra-axonal volume widespread over a high number of white matter tracts. Such microstructural alterations in 16p11.2 deletion children were already present at an early age, and led to significant changes in the global efficiency and integration of brain networks mainly associated to language, motricity and socio-emotional behavior, although the widespread pattern made it unlikely to represent direct functional correlates. Our results shed light on the neuroanatomical basis of the previously reported increase of white matter volume, and align well with analogous evidence of altered axonal diameter and synaptic function in 16p11.2 mice models. We provide evidence of a prevalent mechanistic deviation from typical maturation of brain structural connectivity associated with a specific biological risk to develop ASD. Future work is warranted to determine how this deviation contributes to the emergence of symptoms observed in young children diagnosed with ASD and other NDDs.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Lausanne University Hospital (CHUV), Service des Troubles du Spectre de l’Autisme et apparentés, Département de psychiatrie, Lausanne, Switzerland (GRID:grid.9851.5) (ISNI:0000 0001 2165 4204)
2 University of Southern California (USC), Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, Marina del Rey, USA (GRID:grid.42505.36) (ISNI:0000 0001 2156 6853)
3 Lausanne University Hospital (CHUV), Unité de Neurologie et neuroréhabilitation pédiatrique, Département femme-mère-enfant, Lausanne, Switzerland (GRID:grid.9851.5) (ISNI:0000 0001 2165 4204)
4 Montréal Neurological Institute, Department of Neurology and Neurosurgery, Montréal, Canada (GRID:grid.416102.0) (ISNI:0000 0004 0646 3639); McGill University, McConnell Brain Imaging Center, Montréal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649)
5 Lausanne University Hospital (CHUV), Biomedical Imaging Center (CIBM), Department of Radiology, Lausanne, Switzerland (GRID:grid.9851.5) (ISNI:0000 0001 2165 4204)
6 Sainte Justine Hospital Research Center, Montréal, QC, Canada (GRID:grid.411418.9) (ISNI:0000 0001 2173 6322); University of Montréal, Department of Pediatrics, Montreal, QC, Canada (GRID:grid.14848.31) (ISNI:0000 0001 2104 2136)